Clinical Trial Update: Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) [Phase 2]

View source ↗

Summary

Phase 2 trial update for reduced intensity conditioning in hemophagocytic syndromes and selected primary immune deficiencies completed with posted results in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Epstein-barr Virus Infection
• Granulomatous Disease
• Hemophagocytic Lymphohistiocytosis
• Higm-1
• Ipex
• Leukocyte Adhesion Deficiency

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-06-01